A health worker in Alaska experienced a “severe reaction” and was subsequently hospitalized after receiving a dose of Pfizer’s coronavirus vaccine, which was approved by the Food and Drug Administration (FDA) last week, according to reports.
The employee had what the New York Times described as a “serious reaction” after receiving the vaccination and remained in the hospital from Wednesday morning, according to the newspaper. The employee had “no history of drug allergies,” the Times reported, adding that it “remains unclear whether he or she suffered from other types of allergies, according to a person familiar with the case.”
This month, the UK National Health Service (NHS) confirmed that it provided “resuscitation facilities” at vaccination centers, following reports of two individuals experiencing anaphylactic reactions after receiving the vaccine. However, the two health workers reportedly had a history of allergic reactions.
“Resuscitation facilities must be available at all times for all vaccinations. Vaccination should only be performed in facilities where resuscitation measures are available, ”said the Medicines and Healthcare products Regulatory Agency (MHRA), which offered“ precautionary advice. ”
The FDA approved Pfizer’s vaccine for emergency use on Friday. On Monday, an intensive care nurse from New York reportedly became the first person in the US to receive the Pfizer vaccine outside of clinical trials:
Today, ICU nurse Sandra Lindsay made history as the first American to be vaccinated.
“I felt tremendous relief after taking the vaccine … There is hope.” pic.twitter.com/45RWerTqdX
– Andrew Cuomo (@NYGovCuomo) December 15, 2020
The news coincides with a Kaiser Family Foundation poll published this week that found that an increasing number of Americans have expressed their willingness to receive a vaccine depending on two factors: whether it is considered safe and free. offered. Seventy-one percent said they would be “sure” or “likely” to receive a coronavirus vaccine based on those factors – an eight-point jump from the 63 percent who said the same thing in September.
Willingness to get the vaccination rose among ethnic groups and political parties, the survey found.